OR6K1P

Across TCGA pan-cancer cohorts, OR6K1P RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated OR6K1P data layer.

The strongest signal is observed in kidney renal papillary cell carcinoma (KIRP), where higher OR6K1P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated OR6K1P expression acts as an unfavorable survival marker, although some lineages such as HNSC show a favorable association.

KIRP, PAAD, and KIRC are the cancer types where OR6K1P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRP	OS	Tertile	II,III,IV	0.179	0.759	<.001	93	view →
PAAD	OS	Tertile	All	0.232	0.620	<.001	90	view →
KIRC	DFS	Tertile	III,IV	0.216	0.533	.004	60	view →
ACC	OS	Tertile	All	0.133	0.686	.004	54	view →
CESC	DFS	Tertile	III,IV	0.169	0.645	.001	24	view →
ESCA	DFS	Tertile	All	0.240	0.804	.008	18	view →
SKCM	OS	Tertile	All	0.104	0.400	.006	12	view →
MESO	OS	Tertile	All	0.290	0.551	.045	9	view →
SARC	OS	Tertile	All	0.267	0.734	.007	9	view →
HNSC	OS	Tertile	All	0.875	0.740	.027	3	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

OR6K1P–KIRP (OS)

Open the KIRP breakdown →